<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31896467</PMID><DateCompleted><Year>2021</Year><Month>01</Month><Day>11</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2213-1582</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><PubDate><Year>2020</Year></PubDate></JournalIssue><Title>NeuroImage. Clinical</Title><ISOAbbreviation>Neuroimage Clin</ISOAbbreviation></Journal><ArticleTitle>Applying the D50 disease progression model to gray and white matter pathology in amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>102094</StartPage><MedlinePgn>102094</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">102094</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.nicl.2019.102094</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2213-1582(19)30441-3</ELocationID><Abstract><AbstractText>Therapeutic management and research in Amyotrophic Laterals Sclerosis (ALS) have been limited by the substantial heterogeneity in progression and anatomical spread that are endemic of the disease. Neuroimaging biomarkers represent powerful additions to the current monitoring repertoire but have yielded inconsistent associations with clinical scores like the ALS functional rating scale. The D50 disease progression model was developed to address limitations with clinical indices and the difficulty obtaining longitudinal data in ALS. It yields overall disease aggressiveness as time taken to reach halved functionality (D50); individual disease covered in distinct phases; and calculated functional state and calculated functional loss as acute descriptors of local disease activity. It greatly reduces the noise of the ALS functional rating scale and allows the comparison of highly heterogeneous disease and progression subtypes. In this study, we performed Voxel-Based Morphometry for 85 patients with ALS (60.1&#xa0;&#xb1;&#xa0;11.5 years, 36 female) and 62 healthy controls. Group-wise comparisons were performed separately for gray matter and white matter using ANCOVA testing with threshold-free cluster enhancement. ALS-related widespread gray and white matter density decreases were observed in the bilateral frontal and temporal lobes (p&#xa0;&lt;&#xa0;0.001, family-wise error corrected). We observed a progressive spread of structural alterations along the D50-derived phases, that were primarily located in frontal, temporal and occipital gray matter areas, as well as in supratentorial neuronal projections (p&#xa0;&lt;&#xa0;0.001 family-wise error corrected). ALS patients with higher overall disease aggressiveness (D50 &lt; 30 months) showed a distinct pattern of supratentorial white matter density decreases relative to patients with lower aggressiveness; no significant differences were observed for gray matter density (p&#xa0;&lt;&#xa0;0.001 family-wise error corrected). The application of the D50 disease progression model separates measures of disease aggressiveness from disease accumulation. It revealed a strong correlation between disease phases and in-vivo measures of cerebral structural integrity. This study underscores the proposed corticofugal spread of cerebral pathology in ALS. We recommend application of the D50 model in studies linking clinical data with neuroimaging correlates.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Steinbach</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Hans Berger Department of Neurology, Jena University Hospital, Jena, Germany. Electronic address: Robert.Steinbach@med.uni-jena.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Batyrbekova</LastName><ForeName>Meerim</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Hans Berger Department of Neurology, Jena University Hospital, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gaur</LastName><ForeName>Nayana</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Hans Berger Department of Neurology, Jena University Hospital, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Voss</LastName><ForeName>Annika</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Hans Berger Department of Neurology, Jena University Hospital, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stubendorff</LastName><ForeName>Beatrice</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Hans Berger Department of Neurology, Jena University Hospital, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mayer</LastName><ForeName>Thomas E</ForeName><Initials>TE</Initials><AffiliationInfo><Affiliation>Department of Neuroradiology, Jena University Hospital, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gaser</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Hans Berger Department of Neurology, Jena University Hospital, Jena, Germany; Center for Healthy Ageing, Jena University Hospital, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Witte</LastName><ForeName>Otto W</ForeName><Initials>OW</Initials><AffiliationInfo><Affiliation>Hans Berger Department of Neurology, Jena University Hospital, Jena, Germany; Center for Healthy Ageing, Jena University Hospital, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prell</LastName><ForeName>Tino</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Hans Berger Department of Neurology, Jena University Hospital, Jena, Germany; Center for Healthy Ageing, Jena University Hospital, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grosskreutz</LastName><ForeName>Julian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Hans Berger Department of Neurology, Jena University Hospital, Jena, Germany; Center for Healthy Ageing, Jena University Hospital, Jena, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>11</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Neuroimage Clin</MedlineTA><NlmUniqueID>101597070</NlmUniqueID><ISSNLinking>2213-1582</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="Y">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D066128" MajorTopicYN="Y">Gray Matter</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008959" MajorTopicYN="Y">Models, Neurological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059906" MajorTopicYN="N">Neuroimaging</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D066127" MajorTopicYN="Y">White Matter</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">D50 model</Keyword><Keyword MajorTopicYN="N">Disease progression</Keyword><Keyword MajorTopicYN="N">Magnetic resonance imaging</Keyword><Keyword MajorTopicYN="N">Voxel-Based Morphometry</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest The authors have no conflicts of interest to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>7</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>10</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>11</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>1</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>1</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>1</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31896467</ArticleId><ArticleId IdType="pmc">PMC6940701</ArticleId><ArticleId IdType="doi">10.1016/j.nicl.2019.102094</ArticleId><ArticleId IdType="pii">S2213-1582(19)30441-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Abdulla S., Machts J., Kaufmann J., Patrick K., Kollewe K., Dengler R., Heinze H.J., Petri S., Vielhaber S., Nestor P.J. Hippocampal degeneration in patients with amyotrophic lateral sclerosis. Neurobiol. Aging. 2014;35:2639&#x2013;2645.</Citation><ArticleIdList><ArticleId IdType="pubmed">25004891</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrahams S., Newton J., Niven E., Foley J., Bak T.H. Screening for cognition and behaviour changes in ALS. Amyotroph. Lateral Scler. Frontotemporal Degener. 2014;15:9&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">23781974</ArticleId></ArticleIdList></Reference><Reference><Citation>Acosta-Cabronero J., Machts J., Schreiber S., Abdulla S., Kollewe K., Petri S., Spotorno N., Kaufmann J., Heinze H.J., Dengler R., Vielhaber S., Nestor P.J. Quantitative susceptibility MRI to detect brain iron in amyotrophic lateral sclerosis. Radiology. 2018;289:195&#x2013;203.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6166868</ArticleId><ArticleId IdType="pubmed">30040038</ArticleId></ArticleIdList></Reference><Reference><Citation>Agosta F., Gorno-Tempini M.L., Pagani E., Sala S., Caputo D., Perini M., Bartolomei I., Fruguglietti M.E., Filippi M. Longitudinal assessment of grey matter contraction in amyotrophic lateral sclerosis: a tensor based morphometry study. Amyotroph. Lateral Scler. 2009;10:168&#x2013;174.</Citation><ArticleIdList><ArticleId IdType="pubmed">19058055</ArticleId></ArticleIdList></Reference><Reference><Citation>Agosta F., Pagani E., Rocca M.A., Caputo D., Perini M., Salvi F., Prelle A., Filippi M. Voxel-based morphometry study of brain volumetry and diffusivity in amyotrophic lateral sclerosis patients with mild disability. Hum. Brain Mapp. 2007;28:1430&#x2013;1438.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6871473</ArticleId><ArticleId IdType="pubmed">17370339</ArticleId></ArticleIdList></Reference><Reference><Citation>Agosta F., Valsasina P., Riva N., Copetti M., Messina M.J., Prelle A., Comi G., Filippi M. The cortical signature of amyotrophic lateral sclerosis. PLoS One. 2012;7:e42816.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3412820</ArticleId><ArticleId IdType="pubmed">22880116</ArticleId></ArticleIdList></Reference><Reference><Citation>Alruwaili A.R., Pannek K., Coulthard A., Henderson R., Kurniawan N.D., McCombe P. A combined tract-based spatial statistics and voxel-based morphometry study of the first MRI scan after diagnosis of amyotrophic lateral sclerosis with subgroup analysis. J Neuroradiol. 2018;45:41&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pubmed">28802959</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashburner J., Friston K.J. Voxel-based morphometry&#x2013;the methods. Neuroimage. 2000;11:805&#x2013;821.</Citation><ArticleIdList><ArticleId IdType="pubmed">10860804</ArticleId></ArticleIdList></Reference><Reference><Citation>Bae J.S., Ferguson M., Tan R., Mioshi E., Simon N., Burrell J., Vucic S., Hodges J.R., Kiernan M.C., Hornberger M. Dissociation of structural and functional integrities of the motor system in amyotrophic lateral sclerosis and behavioral-variant frontotemporal dementia. J. Clin. Neurol. 2016;12:209&#x2013;217.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4828568</ArticleId><ArticleId IdType="pubmed">26932257</ArticleId></ArticleIdList></Reference><Reference><Citation>Balendra R., Jones A., Jivraj N., Knights C., Ellis C.M., Burman R., Turner M.R., Leigh P.N., Shaw C.E., Al-Chalabi A. Estimating clinical stage of amyotrophic lateral sclerosis from the ALS functional rating scale. Amyotroph. Lateral Scler. Frontotemporal Degener. 2014;15:279&#x2013;284.</Citation><ArticleIdList><ArticleId IdType="pubmed">24720420</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede P., Bokde A., Elamin M., Byrne S., McLaughlin R.L., Jordan N., Hampel H., Gallagher L., Lynch C., Fagan A.J., Pender N., Hardiman O. Grey matter correlates of clinical variables in amyotrophic lateral sclerosis (ALS): a neuroimaging study of ALS motor phenotype heterogeneity and cortical focality. J. Neurol. Neurosurg. Psychiatry. 2013;84:766&#x2013;773.</Citation><ArticleIdList><ArticleId IdType="pubmed">23085933</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede P., Bokde A.L., Byrne S., Elamin M., McLaughlin R.L., Kenna K., Fagan A.J., Pender N., Bradley D.G., Hardiman O. Multiparametric MRI study of ALS stratified for the C9orf72 genotype. Neurology. 2013;81:361&#x2013;369.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3772833</ArticleId><ArticleId IdType="pubmed">23771489</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede P., Hardiman O. Lessons of ALS imaging: pitfalls and future directions - a critical review. Neuroimage Clin. 2014;4:436&#x2013;443.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3950559</ArticleId><ArticleId IdType="pubmed">24624329</ArticleId></ArticleIdList></Reference><Reference><Citation>Braak H., Brettschneider J., Ludolph A.C., Lee V.M., Trojanowski J.Q., Del Tredici K. Amyotrophic lateral sclerosis&#x2013;a model of corticofugal axonal spread. Nat. Rev. Neurol. 2013;9:708&#x2013;714.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3943211</ArticleId><ArticleId IdType="pubmed">24217521</ArticleId></ArticleIdList></Reference><Reference><Citation>Brettschneider J., Del Tredici K., Toledo J.B., Robinson J.L., Irwin D.J., Grossman M., Suh E., Van Deerlin V.M., Wood E.M., Baek Y., Kwong L., Lee E.B., Elman L., McCluskey L., Fang L., Feldengut S., Ludolph A.C., Lee V.M., Braak H., Trojanowski J.Q. Stages of pTDP-43 pathology in amyotrophic lateral sclerosis. Ann. Neurol. 2013;74:20&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3785076</ArticleId><ArticleId IdType="pubmed">23686809</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks B.R., Miller R.G., Swash M., Munsat T.L. El escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the world federation of neurology. Res. Group Motor Neuron Dis. 2000;1:293&#x2013;299.</Citation><ArticleIdList><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Bueno A.P.A., Pinaya W.H.L., Moura L.M., Bertoux M., Radakovic R., Kiernan M.C., Teixeira A.L., de Souza L.C., Hornberger M., Sato J.R. Structural and functional Papez circuit integrity in amyotrophic lateral sclerosis. Brain Imaging Behav. 2018;12(6):1622&#x2013;1630.</Citation><ArticleIdList><ArticleId IdType="pubmed">29374846</ArticleId></ArticleIdList></Reference><Reference><Citation>Buhour M.S., Doidy F., Mondou A., Pelerin A., Carluer L., Eustache F., Viader F., Desgranges B. Voxel-based mapping of grey matter volume and glucose metabolism profiles in amyotrophic lateral sclerosis. EJNMMI Res. 2017;7:21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5339262</ArticleId><ArticleId IdType="pubmed">28266002</ArticleId></ArticleIdList></Reference><Reference><Citation>Calvo A., Moglia C., Lunetta C., Marinou K., Ticozzi N., Ferrante G.D., Scialo C., Soraru G., Trojsi F., Conte A., Falzone Y.M., Tortelli R., Russo M., Chio A., Sansone V.A., Mora G., Silani V., Volanti P., Caponnetto C., Querin G., Monsurro M.R., Sabatelli M., Riva N., Logroscino G., Messina S., Fini N., Mandrioli J. Factors predicting survival in ALS: a multicenter italian study. J. Neurol. 2017;264:54&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">27778156</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardenas-Blanco A., Machts J., Acosta-Cabronero J., Kaufmann J., Abdulla S., Kollewe K., Petri S., Schreiber S., Heinze H.J., Dengler R., Vielhaber S., Nestor P.J. Structural and diffusion imaging versus clinical assessment to monitor amyotrophic lateral sclerosis. Neuroimage Clin. 2016;11:408&#x2013;414.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4827722</ArticleId><ArticleId IdType="pubmed">27104135</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang J.L., Lomen-Hoerth C., Murphy J., Henry R.G., Kramer J.H., Miller B.L., Gorno-Tempini M.L. A voxel-based morphometry study of patterns of brain atrophy in ALS and ALS/FTLD. Neurology. 2005;65:75&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">16009889</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen G., Zhou B., Zhu H., Kuang W., Bi F., Ai H., Gu Z., Huang X., Lui S., Gong Q. White matter volume loss in amyotrophic lateral sclerosis: a meta-analysis of voxel-based morphometry studies. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2018;83:110&#x2013;117.</Citation><ArticleIdList><ArticleId IdType="pubmed">29330136</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Z.Y., Liu M.Q., Ma L. Gray matter volume changes over the whole brain in the Bulbar- and Spinal-onset amyotrophic lateral sclerosis: a voxel-based morphometry study. Chin. Med. Sci. J. 2018;33:20&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pubmed">29620511</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio A., Hammond E.R., Mora G., Bonito V., Filippini G. Development and evaluation of a clinical staging system for amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry. 2015;86:38&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">24336810</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio A., Pagani M., Agosta F., Calvo A., Cistaro A., Filippi M. Neuroimaging in amyotrophic lateral sclerosis: insights into structural and functional changes. Lancet Neurol. 2014;13:1228&#x2013;1240.</Citation><ArticleIdList><ArticleId IdType="pubmed">25453462</ArticleId></ArticleIdList></Reference><Reference><Citation>Christidi F., Karavasilis E., Riederer F., Zalonis I., Ferentinos P., Velonakis G., Xirou S., Rentzos M., Argiropoulos G., Zouvelou V., Zambelis T., Athanasakos A., Toulas P., Vadikolias K., Efstathopoulos E., Kollias S., Karandreas N., Kelekis N., Evdokimidis I. Gray matter and white matter changes in non-demented amyotrophic lateral sclerosis patients with or without cognitive impairment: a combined voxel-based morphometry and tract-based spatial statistics whole-brain analysis. Brain Imaging Behav. 2018;12:547&#x2013;563.</Citation><ArticleIdList><ArticleId IdType="pubmed">28425061</ArticleId></ArticleIdList></Reference><Reference><Citation>Christidi F., Karavasilis E., Velonakis G., Rentzos M., Zambelis T., Zouvelou V., Xirou S., Ferentinos P., Efstathopoulos E., Kelekis N., Evdokimidis I., Karandreas N. Motor and extra-motor gray matter integrity may underlie neurophysiologic parameters of motor function in amyotrophic lateral sclerosis: a combined voxel-based morphometry and transcranial stimulation study. Brain Imaging Behav. 2018</Citation><ArticleIdList><ArticleId IdType="pubmed">29417490</ArticleId></ArticleIdList></Reference><Reference><Citation>Crespi C., Dodich A., Cappa S.F., Canessa N., Iannaccone S., Corbo M., Lunetta C., Falini A., Cerami C. Multimodal MRI quantification of the common neurostructural bases within the FTD-ALS continuum. Neurobiol. Aging. 2018;62:95&#x2013;104.</Citation><ArticleIdList><ArticleId IdType="pubmed">29131982</ArticleId></ArticleIdList></Reference><Reference><Citation>De Marco M., Merico A., Berta G., Segato N., Citton V., Baglione A., Venneri A. Morphometric correlates of dysarthric deficit in amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Frontotemporal Degener. 2015;16:464&#x2013;472.</Citation><ArticleIdList><ArticleId IdType="pubmed">26121168</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorst J., Ludolph A.C., Huebers A. Disease-modifying and symptomatic treatment of amyotrophic lateral sclerosis. Ther. Adv. Neurol. Disord. 2018;11</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5784546</ArticleId><ArticleId IdType="pubmed">29399045</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisen A., Braak H., Del Tredici K., Lemon R., Ludolph A.C., Kiernan M.C. Cortical influences drive amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry. 2017;88:917&#x2013;924.</Citation><ArticleIdList><ArticleId IdType="pubmed">28710326</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellis C.M., Suckling J., Amaro E., Jr., Bullmore E.T., Simmons A., Williams S.C., Leigh P.N. Volumetric analysis reveals corticospinal tract degeneration and extramotor involvement in ALS. Neurology. 2001;57:1571&#x2013;1578.</Citation><ArticleIdList><ArticleId IdType="pubmed">11706094</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang T., Al Khleifat A., Stahl D.R., Lazo La Torre C., Murphy C., Uk-Mnd Lical S., Young C., Shaw P.J., Leigh P.N., Al-Chalabi A. Comparison of the king's and mitos staging systems for ALS. Amyotroph. Lateral Scler. Frontotemporal Degener. 2017;18:227&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5425622</ArticleId><ArticleId IdType="pubmed">28054828</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferraro D., Consonni D., Fini N., Fasano A., Del Giovane C., Emilia Romagna Registry for, A.L.S.G. Mandrioli J. Amyotrophic lateral sclerosis: a comparison of two staging systems in a population-based study. Eur. J. Neurol. 2016;23:1426&#x2013;1432.</Citation><ArticleIdList><ArticleId IdType="pubmed">27238551</ArticleId></ArticleIdList></Reference><Reference><Citation>Filippi M., Agosta F., Grosskreutz J., Benatar M., Kassubek J., Verstraete E., Turner M.R., Neuroimaging Society in, A.L.S. Progress towards a neuroimaging biomarker for amyotrophic lateral sclerosis. Lancet Neurol. 2015;14:786&#x2013;788.</Citation><ArticleIdList><ArticleId IdType="pubmed">26194923</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein L.H., Abrahams S. Changes in cognition and behaviour in amyotrophic lateral sclerosis: nature of impairment and implications for assessment. Lancet Neurol. 2013;12:368&#x2013;380.</Citation><ArticleIdList><ArticleId IdType="pubmed">23518330</ArticleId></ArticleIdList></Reference><Reference><Citation>Grosskreutz J., Kaufmann J., Fradrich J., Dengler R., Heinze H.J., Peschel T. Widespread sensorimotor and frontal cortical atrophy in amyotrophic lateral sclerosis. BMC Neurol. 2006;6:17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1459868</ArticleId><ArticleId IdType="pubmed">16638121</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartung V., Prell T., Gaser C., Turner M.R., Tietz F., Ilse B., Bokemeyer M., Witte O.W., Grosskreutz J. Voxel-based MRI intensitometry reveals extent of cerebral white matter pathology in amyotrophic lateral sclerosis. PLoS One. 2014;9</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4136773</ArticleId><ArticleId IdType="pubmed">25133577</ArticleId></ArticleIdList></Reference><Reference><Citation>Kassubek J., Unrath A., Huppertz H.J., Lule D., Ethofer T., Sperfeld A.D., Ludolph A.C. Global brain atrophy and corticospinal tract alterations in ALS, as investigated by voxel-based morphometry of 3-D MRI. Amyotroph Lateral Scler. Other Motor Neuron. Disord. 2005;6:213&#x2013;220.</Citation><ArticleIdList><ArticleId IdType="pubmed">16319024</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiernan M.C., Vucic S., Cheah B.C., Turner M.R., Eisen A., Hardiman O., Burrell J.R., Zoing M.C. Amyotrophic lateral sclerosis. Lancet. 2011;377:942&#x2013;955.</Citation><ArticleIdList><ArticleId IdType="pubmed">21296405</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H.J., de Leon M., Wang X., Kim H.Y., Lee Y.J., Kim Y.H., Kim S.H. Relationship between clinical parameters and brain structure in sporadic amyotrophic lateral sclerosis patients according to onset type: a voxel-based morphometric study. PLoS One. 2017;12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5240978</ArticleId><ArticleId IdType="pubmed">28095425</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H.J., Oh S.I., de Leon M., Wang X., Oh K.W., Park J.S., Deshpande A., Buj M., Kim S.H. Structural explanation of poor prognosis of amyotrophic lateral sclerosis in the non-demented state. Eur. J. Neurol. 2017;24:122&#x2013;129.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5436047</ArticleId><ArticleId IdType="pubmed">27753163</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwan J.Y., Meoded A., Danielian L.E., Wu T., Floeter M.K. Structural imaging differences and longitudinal changes in primary lateral sclerosis and amyotrophic lateral sclerosis. Neuroimage Clin. 2012;2:151&#x2013;160.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3778247</ArticleId><ArticleId IdType="pubmed">24179768</ArticleId></ArticleIdList></Reference><Reference><Citation>Machts J., Loewe K., Kaufmann J., Jakubiczka S., Abdulla S., Petri S., Dengler R., Heinze H.J., Vielhaber S., Schoenfeld M.A., Bede P. Basal ganglia pathology in ALS is associated with neuropsychological deficits. Neurology. 2015;85:1301&#x2013;1309.</Citation><ArticleIdList><ArticleId IdType="pubmed">26385880</ArticleId></ArticleIdList></Reference><Reference><Citation>Marin B., Logroscino G., Boumediene F., Labrunie A., Couratier P., Babron M.C., Leutenegger A.L., Preux P.M., Beghi E. Clinical and demographic factors and outcome of amyotrophic lateral sclerosis in relation to population ancestral origin. Eur. J. Epidemiol. 2016;31:229&#x2013;245.</Citation><ArticleIdList><ArticleId IdType="pubmed">26458931</ArticleId></ArticleIdList></Reference><Reference><Citation>Menke R.A., Korner S., Filippini N., Douaud G., Knight S., Talbot K., Turner M.R. Widespread grey matter pathology dominates the longitudinal cerebral MRI and clinical landscape of amyotrophic lateral sclerosis. Brain. 2014;137:2546&#x2013;2555.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4132644</ArticleId><ArticleId IdType="pubmed">24951638</ArticleId></ArticleIdList></Reference><Reference><Citation>Menke R.A.L., Proudfoot M., Talbot K., Turner M.R. The two-year progression of structural and functional cerebral MRI in amyotrophic lateral sclerosis. Neuroimage Clin. 2018;17:953&#x2013;961.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5752097</ArticleId><ArticleId IdType="pubmed">29321969</ArticleId></ArticleIdList></Reference><Reference><Citation>Mezzapesa D.M., Ceccarelli A., Dicuonzo F., Carella A., De Caro M.F., Lopez M., Samarelli V., Livrea P., Simone I.L. Whole-brain and regional brain atrophy in amyotrophic lateral sclerosis. AJNR Am. J. Neuroradiol. 2007;28:255&#x2013;259.</Citation><ArticleIdList><ArticleId IdType="pubmed">17296989</ArticleId></ArticleIdList></Reference><Reference><Citation>Mezzapesa D.M., D'Errico E., Tortelli R., Distaso E., Cortese R., Tursi M., Federico F., Zoccolella S., Logroscino G., Dicuonzo F., Simone I.L. Cortical thinning and clinical heterogeneity in amyotrophic lateral sclerosis. PLoS One. 2013;8:e80748.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3835750</ArticleId><ArticleId IdType="pubmed">24278317</ArticleId></ArticleIdList></Reference><Reference><Citation>Mioshi E., Lillo P., Yew B., Hsieh S., Savage S., Hodges J.R., Kiernan M.C., Hornberger M. Cortical atrophy in ALS is critically associated with neuropsychiatric and cognitive changes. Neurology. 2013;80:1117&#x2013;1123.</Citation><ArticleIdList><ArticleId IdType="pubmed">23427327</ArticleId></ArticleIdList></Reference><Reference><Citation>Montuschi A., Iazzolino B., Calvo A., Moglia C., Lopiano L., Restagno G., Brunetti M., Ossola I., Lo Presti A., Cammarosano S., Canosa A., Chio A. Cognitive correlates in amyotrophic lateral sclerosis: a population-based study in italy. J. Neurol. Neurosurg. Psychiatry. 2015;86:168&#x2013;173.</Citation><ArticleIdList><ArticleId IdType="pubmed">24769471</ArticleId></ArticleIdList></Reference><Reference><Citation>Paipa A.J., Povedano M., Barcelo A., Dominguez R., Saez M., Turon J., Prats E., Farrero E., Virgili N., Martinez J.A., Corbella X. Survival benefit of multidisciplinary care in amyotrophic lateral sclerosis in Spain: association with noninvasive mechanical ventilation. J. Multidiscip. Healthc. 2019;12:465&#x2013;470.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6590410</ArticleId><ArticleId IdType="pubmed">31354285</ArticleId></ArticleIdList></Reference><Reference><Citation>Poesen K., De Schaepdryver M., Stubendorff B., Gille B., Muckova P., Wendler S., Prell T., Ringer T.M., Rhode H., Stevens O., Claeys K.G., Couwelier G., D'Hondt A., Lamaire N., Tilkin P., Van Reijen D., Gourmaud S., Fedtke N., Heiling B., Rumpel M., Rodiger A., Gunkel A., Witte O.W., Paquet C., Vandenberghe R., Grosskreutz J., Van Damme P. Neurofilament markers for ALS correlate with extent of upper and lower motor neuron disease. Neurology. 2017;88:2302&#x2013;2309.</Citation><ArticleIdList><ArticleId IdType="pubmed">28500227</ArticleId></ArticleIdList></Reference><Reference><Citation>Pradat P.F., El Mendili M.M. Neuroimaging to investigate multisystem involvement and provide biomarkers in amyotrophic lateral sclerosis. Biomed. Res. Int. 2014;2014</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4052676</ArticleId><ArticleId IdType="pubmed">24949452</ArticleId></ArticleIdList></Reference><Reference><Citation>Prell T., Stubendorff B., Le T.T., Gaur N., Tadi&#x107; V., R&#xf6;diger A., Witte O.W., Grosskreutz J. Reaction to endoplasmic reticulum stress via ATF6 in amyotrophic lateral sclerosis deteriorates with aging. Front. Aging Neurosci. 2019;11(5)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6355670</ArticleId><ArticleId IdType="pubmed">30740050</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajagopalan V., Liu Z., Allexandre D., Zhang L., Wang X.F., Pioro E.P., Yue G.H. Brain white matter shape changes in amyotrophic lateral sclerosis (ALS): a fractal dimension study. PLoS One. 2013;8:e73614.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3767806</ArticleId><ArticleId IdType="pubmed">24040000</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajagopalan V., Pioro E.P. Comparing brain structural MRI and metabolic FDG-PET changes in patients with ALS-FTD: 'the chicken or the egg?' question. J. Neurol. Neurosurg. Psychiatry. 2015;86:952&#x2013;958.</Citation><ArticleIdList><ArticleId IdType="pubmed">25520437</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajagopalan V., Pioro E.P. Disparate voxel based morphometry (VBM) results between SPM and FSL softwares in ALS patients with frontotemporal dementia: which VBM results to consider? BMC Neurol. 2015;15:32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4371611</ArticleId><ArticleId IdType="pubmed">25879588</ArticleId></ArticleIdList></Reference><Reference><Citation>Roche J.C., Rojas-Garcia R., Scott K.M., Scotton W., Ellis C.E., Burman R., Wijesekera L., Turner M.R., Leigh P.N., Shaw C.E., Al-Chalabi A. A proposed staging system for amyotrophic lateral sclerosis. Brain. 2012;135:847&#x2013;852.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3286327</ArticleId><ArticleId IdType="pubmed">22271664</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuster C., Kasper E., Machts J., Bittner D., Kaufmann J., Benecke R., Teipel S., Vielhaber S., Prudlo J. Focal thinning of the motor cortex mirrors clinical features of amyotrophic lateral sclerosis and their phenotypes: a neuroimaging study. J. Neurol. 2013;260:2856&#x2013;2864.</Citation><ArticleIdList><ArticleId IdType="pubmed">23996101</ArticleId></ArticleIdList></Reference><Reference><Citation>Senda J., Atsuta N., Watanabe H., Bagarinao E., Imai K., Yokoi D., Riku Y., Masuda M., Nakamura R., Watanabe H., Ito M., Katsuno M., Naganawa S., Sobue G. Structural MRI correlates of amyotrophic lateral sclerosis progression. J. Neurol. Neurosurg. Psychiatry. 2017;88:901&#x2013;907.</Citation><ArticleIdList><ArticleId IdType="pubmed">28501822</ArticleId></ArticleIdList></Reference><Reference><Citation>Senda J., Kato S., Kaga T., Ito M., Atsuta N., Nakamura T., Watanabe H., Tanaka F., Naganawa S., Sobue G. Progressive and widespread brain damage in ALS: MRI voxel-based morphometry and diffusion tensor imaging study. Amyotroph. Lateral Scler. 2011;12:59&#x2013;69.</Citation><ArticleIdList><ArticleId IdType="pubmed">21271792</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen D., Cui L., Fang J., Cui B., Li D., Tai H. Voxel-Wise meta-analysis of gray matter changes in amyotrophic lateral sclerosis. Front. Aging Neurosci. 2016;8:64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4811926</ArticleId><ArticleId IdType="pubmed">27065078</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith S.M., Nichols T.E. Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference. Neuroimage. 2009;44:83&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pubmed">18501637</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinbach R., Gaur N., Stubendorff B., Witte O.W., Grosskreutz J. Developing a neuroimaging biomarker for amyotrophic lateral sclerosis: multi-Center data sharing and the road to a "Global cohort". Front. Neurol. 2018;9:1055.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6288231</ArticleId><ArticleId IdType="pubmed">30564187</ArticleId></ArticleIdList></Reference><Reference><Citation>Thivard L., Pradat P.F., Lehericy S., Lacomblez L., Dormont D., Chiras J., Benali H., Meininger V. Diffusion tensor imaging and voxel based morphometry study in amyotrophic lateral sclerosis: relationships with motor disability. J. Neurol. Neurosurg. Psychiatry. 2007;78:889&#x2013;892.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2117724</ArticleId><ArticleId IdType="pubmed">17635981</ArticleId></ArticleIdList></Reference><Reference><Citation>Trojsi F., Caiazzo G., Corbo D., Piccirillo G., Cristillo V., Femiano C., Ferrantino T., Cirillo M., Monsurro M.R., Esposito F., Tedeschi G. Microstructural changes across different clinical milestones of disease in amyotrophic lateral sclerosis. PLoS One. 2015;10</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4368555</ArticleId><ArticleId IdType="pubmed">25793718</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsujimoto M., Senda J., Ishihara T., Niimi Y., Kawai Y., Atsuta N., Watanabe H., Tanaka F., Naganawa S., Sobue G. Behavioral changes in early ALS correlate with voxel-based morphometry and diffusion tensor imaging. J. Neurol. Sci. 2011;307:34&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">21641004</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner M.R., Grosskreutz J., Kassubek J., Abrahams S., Agosta F., Benatar M., Filippi M., Goldstein L.H., van den Heuvel M., Kalra S., Lule D., Mohammadi B., first Neuroimaging Symosium in, A.L.S. Towards a neuroimaging biomarker for amyotrophic lateral sclerosis. Lancet Neurol. 2011;10:400&#x2013;403.</Citation><ArticleIdList><ArticleId IdType="pubmed">21511189</ArticleId></ArticleIdList></Reference><Reference><Citation>Walhout R., Westeneng H.J., Verstraete E., Hendrikse J., Veldink J.H., van den Heuvel M.P., van den Berg L.H. Cortical thickness in ALS: towards a marker for upper motor neuron involvement. J. Neurol. Neurosurg. Psychiatry. 2015;86:288&#x2013;294.</Citation><ArticleIdList><ArticleId IdType="pubmed">25121571</ArticleId></ArticleIdList></Reference><Reference><Citation>Westeneng H.J., Verstraete E., Walhout R., Schmidt R., Hendrikse J., Veldink J.H., van den Heuvel M.P., van den Berg L.H. Subcortical structures in amyotrophic lateral sclerosis. Neurobiol. Aging. 2015;36:1075&#x2013;1082.</Citation><ArticleIdList><ArticleId IdType="pubmed">25281019</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye S., Rosenbohm A., Bohm S., Uttner I., Ji Y., Ludolph A.C., Lule D., Fan D. Cognitive and behavioral impairments in german and chinese ALS populations - a post-hoc comparison of national study data. Amyotroph. Lateral Scler. Frontotemporal Degener. 2019;20:28&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">30472897</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang F., Chen G., He M., Dai J., Shang H., Gong Q., Jia Z. Altered white matter microarchitecture in amyotrophic lateral sclerosis: a voxel-based meta-analysis of diffusion tensor imaging. Neuroimage Clin. 2018;19:122&#x2013;129.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6051469</ArticleId><ArticleId IdType="pubmed">30035009</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q., Mao C., Jin J., Niu C., Bai L., Dang J., Zhang M. Side of limb-onset predicts laterality of gray matter loss in amyotrophic lateral sclerosis. Biomed. Res. Int. 2014;2014</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4100370</ArticleId><ArticleId IdType="pubmed">25093168</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu W., Fu X., Cui F., Yang F., Ren Y., Zhang X., Zhang X., Chen Z., Ling L., Huang X. ALFF value in right parahippocampal gyrus acts as a potential marker monitoring amyotrophic lateral sclerosis progression: a neuropsychological, voxel-based morphometry, and resting-state functional MRI study. J. Mol. Neurosci. 2015;57:106&#x2013;113.</Citation><ArticleIdList><ArticleId IdType="pubmed">26041566</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>